Clinical Trial Details

Trial ID: L0615
Source ID: IRCT201309188308N3
Associated Drug: N-Acetylsyctein
Title: Comparison of the effectivness of N-Acetylsyctein, Pioglitazon and Metformin in the treatment of non alcoholic fatty liver disease
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non Alcoholic Fatty Liver Disease. <br>Nonalcoholic steatohepatitis;Nonalcoholic steatohepatitis
Interventions: Intervention 1: Third group: metformin tablets 500 mg every 12 hours for two months. Intervention 2: Second group pioglitazone 30 mg tablets for two months. Intervention 3: First group: N-acetylcysteine 600 mg tablets for two months.;Treatment - Drugs;Tre
Outcome Measures: Liver enzymes. Timepoint: two month. Method of measurement: Labratory.Grading of Steatosis. Timepoint: two month. Method of measurement: Sonography.
Sponsor/Collaborators: Vice Chancellor for Research and Technology University of Medical Sciences of Hamedan
Gender: All
Age: 20 years80 years
Phases: Phase 3
Enrollment: 60
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 23/02/2015
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/8754